CD44 and Familial prostate cancer: By immunoprecipitation and mass spectrometry, previous studies identified CD13, CD44, Na+/K+ ATPase, and cytoskeleton proteins as proteins that expressed the antigen for the prostate cancer-specific mAb F77 [14].